Immunological Data Discovery Index
Advanced Search
identifier: SDY1109
description:
We performed DENV-specific epitope screening studies in the general population of Managua. Peptides with the capacity to bind HLA DR molecules most common in the Nicaraguan population have been predicted and screened in an HLA matched fashion in blood donors from the Nicaraguan Red Cross previously exposed to dengue virus.
aggregation:
instance of dataset
refinement:
2 - Complete set of descriptive data and results, as ascertained by ImmPort.
availability:
available with registration
isAbout:
To identify and define CD4 epitopes in the general Nicaraguan population.
clinical trial:
study category: Infection Response
study type: Observational
subject species: Homo sapiens
biosample type: PBMC
subject gender: Unknown
assay type: ELISPOT
HLA Typing
name:
Dengue virus-specific epitope screening
fullName:
Alessandro Sette
affiliations:
La Jolla Institute for Allergy and Immunology
roles:
principal investigator
name:
CD4 Nicaragua Epitope ID
size:
128
name:
Protective Immunity Following Dengue Virus Natural Infections and Vaccination
output:
HLA Typing, ELISPOT
studyGroups:
Nicaragua National Blood Bank Study: Buffy coats are collected from the Nicaraguan Red Cross blood bank. PBMCs are isolated and then shipped to the U.S.
description:
We performed DENV-specific epitope screening studies in the general population of Managua. Peptides with the capacity to bind HLA DR molecules most common in the Nicaraguan population have been predicted and screened in an HLA matched fashion in blood donors from the Nicaraguan Red Cross previously exposed to dengue virus.
identifier:
10.21430/M3VF5F8ANE
startDate:
2015-07-29
name:
ImmPort
identifier:
SCR:012804
homePage: http://www.immport.org

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on Feedback.